Lantern Pharma (LTRN) Share-based Compensation (2021 - 2026)
Lantern Pharma's Share-based Compensation came in at $285,260 for Q2 2026, up 77.6% from $160,626 a year earlier and up 8.5% from the prior quarter.
Powered by 
Analysis
Lantern Pharma (LTRN) Share-based Compensation (2021 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Lantern Pharma reported Share-based Compensation of $890,799, up 15.2% year-over-year; for FY2025, it was $651,000, down 11.2% from FY2024.
- Share-based Compensation has declined in each of the last three years, with a four-year compound annual growth rate of -9.3% (FY2021 to FY2025).
- Going back by year, Share-based Compensation was $732,893 in FY2024 (-31.3%), $1.07 million in FY2023 (-10.1%), $1.19 million in FY2022 (+23.5%) and $961,545 in FY2021.
- The Q2 2026 figure represents the highest quarterly Share-based Compensation since Q4 2024.
- Year-over-year, Share-based Compensation increased in five of the last eight quarters, with growth averaging 27.3%.
- The fastest year-over-year change in Share-based Compensation over five years came in Q4 2024 (growth of 89.3%), and the weakest in Q2 2024 (a decline of 65.8%).
- Business Quant data shows LTRN's Share-based Compensation at $262,915 (Q1 2026), $198,939 (Q4 2025) and $143,685 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,159.35 Bn | 1,127.94 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 625.57 Bn | 544.10 Bn | 17.26 Bn | 458.00 Mn |
| 3 | AbbVie | 510.56 Bn | 483.67 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 366.80 Bn | 321.17 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 296.71 Bn | 260.70 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 260.68 Bn | 234.36 Bn | 12.86 Bn | - |
| 7 | Amgen | 235.19 Bn | 190.59 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 194.90 Bn | 169.09 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 171.45 Bn | 118.10 Bn | 10.94 Bn | 249.00 Mn |
| 10 | Lantern Pharma | 7.63 Mn | -28.53 Mn | - | 285,260.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 285,260.00 |
| Mar 31, 2026 | 262,915.00 |
| Dec 31, 2025 | 198,939.00 |
| Sep 30, 2025 | 143,685.00 |
| Jun 30, 2025 | 160,626.00 |
| Mar 31, 2025 | 147,750.00 |
| Dec 31, 2024 | 285,499.00 |
| Sep 30, 2024 | 179,166.00 |
| Jun 30, 2024 | 134,171.00 |
| Mar 31, 2024 | 134,057.00 |
| Dec 31, 2023 | 150,840.00 |
| Sep 30, 2023 | 190,755.00 |
| Jun 30, 2023 | 392,390.00 |
| Mar 31, 2023 | 333,530.00 |
| Dec 31, 2022 | 330,095.00 |
| Sep 30, 2022 | 301,113.00 |
| Jun 30, 2022 | 289,533.00 |
| Mar 31, 2022 | 267,004.00 |
| Dec 31, 2021 | 245,929.00 |
| Sep 30, 2021 | 224,413.00 |
API Access
Lantern Pharma Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=LTRN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "LTRN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=LTRN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();